Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance.
Kuwana M, Sugiyama N, Momohara S, Atsumi T, Takei S, Tamura N, Harigai M, Fujii T, Matsuno H, Takeuchi T, Yamamoto K, Takasaki Y, Tanigawa M, Endo Y, Hirose T, Morishima Y, Yoshii N, Mimori T, Takagi M.
Kuwana M, et al. Among authors: hirose t.
Mod Rheumatol. 2024 Feb 26;34(2):272-286. doi: 10.1093/mr/road063.
Mod Rheumatol. 2024.
PMID: 37405710